Progyny (PGNY) Cash & Current Investments (2018 - 2026)

Progyny (PGNY) has reported Cash & Current Investments for 9 consecutive years, with $236.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Current Investments fell 22.34% year-over-year to $236.9 million in Q2 2026; TTM through Jun 2026 was $236.9 million, a 22.34% decrease from a year earlier, with the FY2025 full-year figure at $310.1 million, up 36.03% from the prior year.
• Cash & Current Investments was $236.9 million for Q2 2026 at Progyny, up from $225.1 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $371.8 million in Q1 2024 and troughed at $105.7 million in Q1 2022.
• A 5-year average of $251.8 million and a median of $246.5 million in 2025 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments soared 137.99% in 2023 and sank 38.57% in 2024, its largest moves.
• Over 5 years, Cash & Current Investments stood at $189.3 million in 2022, then soared by 96.03% to $371.1 million in 2023, then slumped by 38.57% to $228.0 million in 2024, then jumped by 36.03% to $310.1 million in 2025, then decreased by 23.6% to $236.9 million in 2026.
• The last three Cash & Current Investments figures came in at $236.9 million (Q2 2026), $225.1 million (Q1 2026), and $310.1 million (Q4 2025), per Business Quant data.